They should not get sick with that specific flu (but could with others).
Hemagglutination?
these are the allo antibodies produced against the foreign cells in a transfused patient usually foun in patients with multiple transfusions
The red blood cells are destroyed by antibodies produced by the patient's own body (autoantibodies).
Vaccination is only a preventative measure, it will not cure influenza.
When a patient acts against a physicians orders, the physician is able to refuse the patient further care. The patient gives his or her opinion and if you don't follow directions they may wish to terminate your patient status.
A DNA vaccine contains DNA from a pathogen but cannot cause disease. When the vaccine is injected into a patient, the DNA directs the synthesis of a protein. Antibodies are produced by the body against the protein. If the patient contracts the disease in the future, the antibodies in his or her body will be able to provide protection.
Theoretically it is possible to get antibodies from the serum of recovered patient of H1N1. But it will be available in very less quantity. Second question is to whom you will give these antibodies. Thirdly the protection will not be lasting. As this is passive immunity.
Yes, lupus antibodies can *come and go*. Usually antibodies remain present in the patient, but they may be more difficult to find in a blood test. It is possible to have lupus and have negative antibodies.
hyperimmune specific antibodies
One code is 90471. There is a 2nd code for the actual influenza vaccine, but we need to know the age of the patient.
Western blotting. When Western blotting is used for identification purposes, proteins from a known organism are used to determine whether a patient's serum contains antibodies.
Yes, Herceptin is a drug used in certain form of breast cancer which overexpresses the HER-2 protein, enabling angiogenesis and rapid tumour growth. Herceptin is the trade name for monoclonal antibodies against the HER-2 receptor which block these, limiting their function and improving patient prognosis. There are other examples to, monoclonal antibodies against IgE antibody to prevent type 1 hypersentivity e.g. peanut allergy.